Beranda › Gagal Jantung › Vermont
Uji klinis Gagal Jantung di Vermont
8 studi untuk Gagal Jantung mencari peserta di lokasi di Vermont.
Kota di Vermont
Teks studi resmi (Bahasa Inggris)
ELEVATE-HFpEF Clinical Study
- The University of Vermont Medical Center, Burlington
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06678841Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Burlington
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Burlington, VT Investigative Site 10053, Burlington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06008197Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Burlington
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT00271180A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10053, Burlington, VT, Burlington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Vermont, Burlington
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487His-Bundle Corrective Pacing in Heart Failure
- University of Vermont, Burlington
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT05265520Left vs Left Randomized Clinical Trial
- University of Vermont, Burlington
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2025 · NCT05650658Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.